Evidence map›Paper›PMID 27098192›Full record

ArticleBMC biology2016

Loss of the interferon-γ-inducible regulatory immunity-related GTPase (IRG), Irgm1, causes activation of effector IRG proteins on lysosomes, damaging lysosomal function and predicting the dramatic susceptibility of Irgm1-deficient mice to infection.

Jelena Maric-Biresev, Julia P Hunn, Oleg Krut, J Bernd Helms, Sascha Martens, Jonathan C Howard

Open access · goldAbstract read
In one paragraph

Article in BMC biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Irgm1 Restrains CD8European journal of immunology · 2026
    Article
  3. Article
  4. Article
  5. Autophagy and Bacterial infections.Autophagy reports · 2025
    Review
  6. Article
  7. Quantitative Proteomic Analysis of Macrophages Infected withInternational journal of molecular sciences · 2024
    Article
  8. Review
  9. Type I IFN signaling in the absence of IRGM1 promotesbioRxiv : the preprint server for biology · 2023
    Article
  10. Article
  11. Review
  12. Immunity-related GTPase IRGM at the intersection of autophagy, inflammation, and tumorigenesis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Cell-autonomousLife science alliance · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 4 countries.

Jelena Maric-BiresevInstitute for Genetics, University of Cologne, Cologne, Germany.
Julia P HunnDepartment for Biochemistry and Cell Biology, Faculty of Veterinary Medicine and Institute of Biomembranes, Utrecht University, Utrecht, The Netherlands.
Oleg KrutInstitute for Medical Microbiology, Immunology and Hygiene, University Hospital Cologne, Cologne, Germany.
J Bernd HelmsDepartment for Biochemistry and Cell Biology, Faculty of Veterinary Medicine and Institute of Biomembranes, Utrecht University, Utrecht, The Netherlands.
Sascha MartensMax F. Perutz Laboratories, University of Vienna, Vienna, Austria.
Jonathan C HowardInstitute for Genetics, University of Cologne, Cologne, Germany. jhoward@igc.gulbenkian.pt.
Utrecht University · NLInstituto Gulbenkian de Ciência · PTUniversity Hospital Cologne · DEUniversity of Cologne · DEUniversity of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe interferon-γ (IFN-γ)-inducible immunity-related GTPase (IRG), Irgm1, plays an essential role in restraining activation of the IRG pathogen resistance system. However, the loss of Irgm1 in mice also causes a dramatic but unexplained susceptibility phenotype upon infection with a variety of pathogens, including many not normally controlled by the IRG system. This phenotype is associated with lymphopenia, hemopoietic collapse, and death of the mouse.

resultsWe show that the three regulatory IRG proteins (GMS sub-family), including Irgm1, each of which localizes to distinct sets of endocellular membranes, play an important role during the cellular response to IFN-γ, each protecting specific membranes from off-target activation of effector IRG proteins (GKS sub-family). In the absence of Irgm1, which is localized mainly at lysosomal and Golgi membranes, activated GKS proteins load onto lysosomes, and are associated with reduced lysosomal acidity and failure to process autophagosomes. Another GMS protein, Irgm3, is localized to endoplasmic reticulum (ER) membranes; in the Irgm3-deficient mouse, activated GKS proteins are found at the ER. The Irgm3-deficient mouse does not show the drastic phenotype of the Irgm1 mouse. In the Irgm1/Irgm3 double knock-out mouse, activated GKS proteins associate with lipid droplets, but not with lysosomes, and the Irgm1/Irgm3(-/-) does not have the generalized immunodeficiency phenotype expected from its Irgm1 deficiency.

conclusionsThe membrane targeting properties of the three GMS proteins to specific endocellular membranes prevent accumulation of activated GKS protein effectors on the corresponding membranes and thus enable GKS proteins to distinguish organellar cellular membranes from the membranes of pathogen vacuoles. Our data suggest that the generalized lymphomyeloid collapse that occurs in Irgm1(-/-) mice upon infection with a variety of pathogens may be due to lysosomal damage caused by off-target activation of GKS proteins on lysosomal membranes and consequent failure of autophagosomal processing.

Indexed as

AnimalsAutophagyCell LineGene DeletionGTP-Binding ProteinsGTP PhosphohydrolasesImmunity, InnateInfectionsLysosomesMiceMice, Inbred C57BLGTP-Binding ProteinsGTP PhosphohydrolasesIfi1 protein, mouseIgtp protein, mouseIigp1 protein, mouseAutophagyImmunity-related GTPasesIrgm1Irgm3IRGsLysosomesPathogen recognition

Identifiers

PMID27098192
PMCPMC4837601
OpenAlexW2339742875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.